FDA Approves New Breast Cancer Pill After Hormone Therapy Stops Working
There is a new option for breast cancer patients whose cancer has stopped responding to hormone therapy. The Food and Drug Administration (FDA) has approved a daily pill, giredestrant, which should be taken in combination with the cancer drug everolimus. …